Literature DB >> 12894574

Marker-assisted study of genetic background and gene-targeted locus modifiers in lymphopoietic phenotypes.

Demetri D Spyropoulos1, Frank O Bartel, Tsukasa Higuchi, Takao Deguchi, Makio Ogawa, Dennis K Watson.   

Abstract

Forward and reverse genetic approaches facilitate the molecular dissection of individual gene functions and the integration of individual gene functions into multi-gene processes in the context of the whole organism. Variations in mutant phenotypes due to genetic background differences have been well documented through the analysis of mouse mutants. Nevertheless, recommendations concerning the assessment of genetic background as it impacts on phenotype, and utilization of genetic background differences to identify and integrate gene functions have been largely overlooked. Genetic background as it relates to immunological mutants will be discussed utilizing an Ets1-targeted allele to exemplify phenotypic variation due to background. Marker-assisted strategies for the identification of genetic modifiers, especially those linked to the targeted locus, will also be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894574

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  High-throughput screening in primary neurons.

Authors:  Punita Sharma; D Michael Ando; Aaron Daub; Julia A Kaye; Steven Finkbeiner
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.

Authors:  Tsukasa Higuchi; Frank O Bartel; Masahiro Masuya; Takao Deguchi; Kelly W Henderson; Runzhao Li; Robin C Muise-Helmericks; Michael J Kern; Dennis K Watson; Demetri D Spyropoulos
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

3.  Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.

Authors:  Harry J Han; Carolyn C Allen; Christie M Buchovecky; Michael J Yetman; Heather A Born; Miguel A Marin; Shaefali P Rodgers; Bryan J Song; Hui-Chen Lu; Monica J Justice; Frank J Probst; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.